Alto Precision Revenue and Competitors

Wyoming, MI USA

Location

N/A

Total Funding

Machinery

Industry

Estimated Revenue & Valuation

  • Alto Precision's estimated annual revenue is currently $11.3M per year.(i)
  • Alto Precision's estimated revenue per employee is $282,400

Employee Data

  • Alto Precision has 40 Employees.(i)
  • Alto Precision grew their employee count by 8% last year.

Alto Precision's People

NameTitleEmail/Phone
1
VP Sales and MarketingReveal Email/Phone
2
Purchasing Manager/ERP CoordinatorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$10.7M386%N/AN/A
#2
$8.5M3043%N/AN/A
#3
$30.4M8615%N/AN/A
#4
$77.7M2004%N/AN/A
#5
$42.7M1218%N/AN/A
#6
$18.7M597%N/AN/A
#7
$12.4M44-2%N/AN/A
#8
$6.4M264%N/AN/A
#9
$60.6M1566%N/AN/A
#10
$20.3M64-18%N/AN/A
Add Company

What Is Alto Precision?

Alto Precision has been building a variety of high quality machinery since 1982. Alto Precision offers services and equipment that are tailored to your needs. We offer you a dedicated team of engineers, designers, machine builders and market experts that develop solutions to keep you on the leading edge of your industry.

keywords:N/A

N/A

Total Funding

40

Number of Employees

$11.3M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Alto Precision News

2022-04-17 - Movers & Shakers, April 15: Spruce, Nautilus, Alto, Ikena ...

Patel held positions at Precision for Medicine, Janssen, Elan Pharmaceuticals and Genentech. Bilinski was previously the executive director of...

2022-04-13 - Industry Veteran Mikael Eliasson, M.D., Ph.D., Joins Alto ...

Alto Neuroscience is pioneering precision psychiatry by developing targeted medicines to help patients get better faster.

2022-03-22 - Precision Medicine for Mental Illness

Alto Neuroscience wants to use EEG brain biomarkers to better match the right treatment to a person's needs.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.6M4018%N/A
#2
$10.8M4124%N/A
#3
$11.4M44-4%N/A
#4
$7.5M4513%N/A
#5
$15M4715%N/A